Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Birth control pills can help reduce mild to moderate acne in women.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.